238 related articles for article (PubMed ID: 33397671)
1. Prevalence and incidence of microvascular and macrovascular complications over 15 years among patients with incident type 2 diabetes.
An J; Nichols GA; Qian L; Munis MA; Harrison TN; Li Z; Wei R; Weiss T; Rajpathak S; Reynolds K
BMJ Open Diabetes Res Care; 2021 Jan; 9(1):. PubMed ID: 33397671
[TBL] [Abstract][Full Text] [Related]
2. Incidence rates and predictors of microvascular and macrovascular complications in patients with type 2 diabetes: Results from the longitudinal global discover study.
Arnold SV; Khunti K; Tang F; Chen H; Cid-Ruzafa J; Cooper A; Fenici P; Gomes MB; Hammar N; Ji L; Saraiva GL; Medina J; Nicolucci A; Ramirez L; Rathmann W; Shestakova MV; Shimomura I; Surmont F; Vora J; Watada H; Kosiborod M
Am Heart J; 2022 Jan; 243():232-239. PubMed ID: 34666013
[TBL] [Abstract][Full Text] [Related]
3. BMI and BMI change following incident type 2 diabetes and risk of microvascular and macrovascular complications: the EPIC-Potsdam study.
Polemiti E; Baudry J; Kuxhaus O; Jäger S; Bergmann MM; Weikert C; Schulze MB
Diabetologia; 2021 Apr; 64(4):814-825. PubMed ID: 33452586
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of micro- and macrovascular diabetes complications at time of type 2 diabetes diagnosis and associated clinical characteristics: A cross-sectional baseline study of 6958 patients in the Danish DD2 cohort.
Gedebjerg A; Almdal TP; Berencsi K; Rungby J; Nielsen JS; Witte DR; Friborg S; Brandslund I; Vaag A; Beck-Nielsen H; Sørensen HT; Thomsen RW
J Diabetes Complications; 2018 Jan; 32(1):34-40. PubMed ID: 29107454
[TBL] [Abstract][Full Text] [Related]
5. Nocturnal hypoxemic burden and micro- and macrovascular disease in patients with type 2 diabetes.
Driendl S; Stadler S; Arzt M; Zeman F; Heid IM; Baumert M
Cardiovasc Diabetol; 2024 Jun; 23(1):195. PubMed ID: 38844945
[TBL] [Abstract][Full Text] [Related]
6. Chronic complications in patients with newly diagnosed type 2 diabetes: prevalence and related metabolic and clinical features: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 9.
Bonora E; Trombetta M; Dauriz M; Travia D; Cacciatori V; Brangani C; Negri C; Perrone F; Pichiri I; Stoico V; Zoppini G; Rinaldi E; Da Prato G; Boselli ML; Santi L; Moschetta F; Zardini M; Bonadonna RC
BMJ Open Diabetes Res Care; 2020 Aug; 8(1):. PubMed ID: 32819978
[TBL] [Abstract][Full Text] [Related]
7. Earlier Age of Onset of Chronic Hypertension and Type 2 Diabetes Mellitus After a Hypertensive Disorder of Pregnancy or Gestational Diabetes Mellitus.
Heida KY; Franx A; van Rijn BB; Eijkemans MJ; Boer JM; Verschuren MW; Oudijk MA; Bots ML; van der Schouw YT
Hypertension; 2015 Dec; 66(6):1116-22. PubMed ID: 26459420
[TBL] [Abstract][Full Text] [Related]
8. Preserved Ratio Impaired Spirometry and Risks of Macrovascular, Microvascular Complications and Mortality Among Individuals With Type 2 Diabetes.
Li G; Jankowich MD; Wu L; Lu Y; Shao L; Lu X; Fan Y; Pan CW; Wu Y; Ke C
Chest; 2023 Nov; 164(5):1268-1280. PubMed ID: 37356807
[TBL] [Abstract][Full Text] [Related]
9. Complications in young adults with early-onset type 2 diabetes: losing the relative protection of youth.
Hillier TA; Pedula KL
Diabetes Care; 2003 Nov; 26(11):2999-3005. PubMed ID: 14578230
[TBL] [Abstract][Full Text] [Related]
10. Diabetes type 2 in the Berlin Aging Study II: Cross-sectional and longitudinal data on prevalence, incidence and severity over on average seven years of follow-up.
Spieker J; Vetter VM; Drewelies J; Spira D; Steinhagen-Thiessen E; Regitz-Zagrosek V; Buchmann N; Demuth I
Diabet Med; 2023 Aug; 40(8):e15104. PubMed ID: 37012605
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, incidence and predictors of cardiovascular risk factors: longitudinal data from rural and urban South India and comparison with global data.
Vasan SK; Antonisamy B; Gowri M; Selliah HY; Geethanjali FS; Jebasingh FS; Paul TV; Thomas N; Karpe F; Johnson M; Osmond C; Fall CHD
BMJ Open Diabetes Res Care; 2020 Oct; 8(1):. PubMed ID: 33093130
[TBL] [Abstract][Full Text] [Related]
12. Risk factors, outcomes and healthcare utilisation in individuals with multimorbidity including heart failure, chronic kidney disease and type 2 diabetes mellitus: a national electronic health record study.
Pasea L; Dashtban A; Mizani M; Bhuva A; Morris T; Mamza JB; Banerjee A
Open Heart; 2023 Sep; 10(2):. PubMed ID: 37758654
[TBL] [Abstract][Full Text] [Related]
13. Trends in Cause-Specific Outcomes Among Individuals With Type 2 Diabetes and Heart Failure in the United Kingdom, 1998-2017.
Lawson CA; Zaccardi F; McCann GP; Davies MJ; Kadam UT; Khunti K
JAMA Netw Open; 2019 Dec; 2(12):e1916447. PubMed ID: 31790564
[TBL] [Abstract][Full Text] [Related]
14. Association of hemoglobin A1c time in range with risk for diabetes complications.
Mohr DC; Zhang L; Prentice JC; Nelson RE; Li D; Pleasants E; Conlin PR
BMJ Open Diabetes Res Care; 2022 Jul; 10(4):. PubMed ID: 35820708
[TBL] [Abstract][Full Text] [Related]
15. Incidence and Prevalence of Microvascular and Macrovascular Diseases and All-cause Mortality in Type 2 Diabetes Mellitus: A 10-year Study in a US Commercially Insured and Medicare Advantage Population.
Visaria J; Iyer NN; Raval A; Kong S; Hobbs T; Bouchard J; Kern DM; Willey V
Clin Ther; 2019 Aug; 41(8):1522-1536.e1. PubMed ID: 31196656
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular events and mortality in chronic kidney disease in primary care patients with previous type 2 diabetes and/or hypertension. A population-based epidemiological study (KIDNEES).
Cunillera-Puértolas O; Vizcaya D; Cerain-Herrero MJ; Gil-Terrón N; Cobo-Guerrero S; Salvador-González B
BMC Nephrol; 2022 Nov; 23(1):376. PubMed ID: 36585634
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of hypertension and dyslipidemia and their associations with micro- and macrovascular diseases in patients with diabetes in Taiwan: an analysis of nationwide data for 2000-2009.
Tseng LN; Tseng YH; Jiang YD; Chang CH; Chung CH; Lin BJ; Chuang LM; Tai TY; Sheu WH
J Formos Med Assoc; 2012 Nov; 111(11):625-36. PubMed ID: 23217598
[TBL] [Abstract][Full Text] [Related]
18. Estimation of chronic kidney disease incidence from prevalence and mortality data in American Indians with type 2 diabetes.
Vijayakumar P; Hoyer A; Nelson RG; Brinks R; Pavkov ME
PLoS One; 2017; 12(2):e0171027. PubMed ID: 28166298
[TBL] [Abstract][Full Text] [Related]
19. The cost of treating type 2 diabetes (CODEIRE).
Nolan JJ; O'Halloran D; McKenna TJ; Firth R; Redmond S
Ir Med J; 2006; 99(10):307-10. PubMed ID: 17274175
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
